These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 3096218)
1. [Comparative clinical study of SF-SP therapy and SF-SP plus BH-AC therapy in gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Study Group]. Izumi T; Yoshida M; Kamaro T; Sato H Gan To Kagaku Ryoho; 1986 Oct; 13(11):3215-20. PubMed ID: 3096218 [TBL] [Abstract][Full Text] [Related]
2. [Comparative clinical study of MF(mitomycin and 5-fluorouracil) and MF.BH-AC therapy]. Satou H; Kamano T; Izumi T; Yoshida M Gan To Kagaku Ryoho; 1986 Sep; 13(9):2807-12. PubMed ID: 3530137 [TBL] [Abstract][Full Text] [Related]
3. [Joint clinical Phase II study of SF-SP]. Sato T; Sato H; Hanatani Y Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321 [TBL] [Abstract][Full Text] [Related]
4. [Clinical trial on the effect of tegafur (SF-SP)]. Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685 [TBL] [Abstract][Full Text] [Related]
5. [Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers]. Ibayashi J Gan To Kagaku Ryoho; 1984 Jul; 11(7):1414-9. PubMed ID: 6430244 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs]. Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120 [TBL] [Abstract][Full Text] [Related]
7. [Cooperative phase II study of spansule tegafur (SF-SP)]. Taguchi T Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250 [TBL] [Abstract][Full Text] [Related]
8. [Phase II study of sustained released granules of tegafur (SF-SP) on inoperable or recurrent gastric cancer]. Sakata Y; Yoshida Y Gan To Kagaku Ryoho; 1985 May; 12(5):1068-72. PubMed ID: 3922308 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study on two different types of tegafur for recurrent breast cancer]. Taguchi T Gan To Kagaku Ryoho; 1984 Feb; 11(2):312-8. PubMed ID: 6421249 [TBL] [Abstract][Full Text] [Related]
10. [Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP]. Irie K; Yasutake K; Imamura Y; Yoshimura Y; Nakamura T; Yoshida M; Fujisawa T; Nishimura S; Mizogami H; Sawada Y Gan To Kagaku Ryoho; 1986 May; 13(5):1893-6. PubMed ID: 3085595 [TBL] [Abstract][Full Text] [Related]
11. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group]. Futatsuki K; Komita T; Kamano T; Watanabe H Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478 [TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer]. Koda K; Kure T; Terada S; Arai R; Morita K; Hirayama M; Terui T; Fukushi A; Yoshizaki N; Nakazawa O Gan No Rinsho; 1987 Sep; 33(11):1329-35. PubMed ID: 3118075 [TBL] [Abstract][Full Text] [Related]
13. [A multicenter comparative study in patients with liver metastasis to compare tegafur in new forms with existing drugs. SF-RC.SF-SP Comparative Study Group]. Kashii A; Kogure H Gan To Kagaku Ryoho; 1989 Jul; 16(7):2387-92. PubMed ID: 2502074 [TBL] [Abstract][Full Text] [Related]
14. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice]. Watanabe A; Kuriyama H; Kiyota T Gan To Kagaku Ryoho; 1996 Feb; 23(3):291-6. PubMed ID: 8712821 [TBL] [Abstract][Full Text] [Related]
15. [Results of phase III study of lentinan]. Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510 [TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial. Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T; Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061 [TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of S-1, a new anticancer agent, in patients with advanced gastrointestinal cancer. S-1 Cooperative Gastrointestinal Study Group]. Maehara Y; Sugimachi K; Kurihara M; Taguchi T Gan To Kagaku Ryoho; 1999 Mar; 26(4):476-85. PubMed ID: 10097744 [TBL] [Abstract][Full Text] [Related]
18. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study. Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369 [TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study. Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313 [TBL] [Abstract][Full Text] [Related]
20. [Biochemical modulation of 5-FU--effect of low dose CDDP]. Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]